The Global Corneal Ulcer Treatment Industry is poised for remarkable growth, with an anticipated Compound Annual Growth Rate (CAGR) of 5.7% from 2022 to 2029. As of 2022, the market is estimated to be valued at approximately US$ 867.3 million, according to industry forecasts.
Future Market Insights’ latest projections reveal a substantial dominance of antibiotics, holding around 76.4% share in 2021 within the Global Corneal Ulcer Treatment Industry. This underscores the pivotal role antibiotics play in addressing and managing corneal ulcer cases worldwide.
Corneal ulcers, though challenging, represent a significant market opportunity for innovative treatment approaches. The projected CAGR signals a growing demand for advanced solutions, driving both research and development initiatives within the pharmaceutical and healthcare sectors.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-6953
Key Takeaways of Global Corneal Ulcer Treatment Industry Study
- Treatment of broad-spectrum corneal ulcers using antibiotics is expected to gain traction and contribute more than 75% of revenue share during the forecast period.
- Growing bacterial keratitis requiring antibiotics for treatment will contribute significantly to the revenue share of the segment.
- Eye drops or eye ointments dominate the market by form type, as these are relatively cheaper and do not require another interventional and oral route for drug delivery.
- By distribution channel, retail pharmacies are expected to gain more than 50% of the market share during the forecast period.
- North America is dominating the Global Corneal Ulcer Treatment Industry, while East Asia is expected to offer lucrative growth opportunities, owing to rising healthcare infrastructure and industrialization.
“Low-cost drugs being offered by generic drug manufacturers, especially in emerging countries, has substantially lowered treatment cost, and is giving tough competition to key players in the Global Corneal Ulcer Treatment Industry,” Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Acquisition – Key Strategy Followed by Leading Manufacturers
Leading manufacturers in the Global Corneal Ulcer Treatment Industry are focusing on geographical expansion as well as increased product offerings through partnerships and acquisitions. To evaluate cost-effective therapy for corneal ulcer treatment, manufacturers are evaluating new drugs via clinical trials For example, in Dec. 2019, Mallinckrodt plc enrolled the first patient in the company’s Phase 4, multi-center, multiple-dose, open-label study to assess the effects of Acthar Gel as a therapy option in patients with severe keratitis.
Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-6953
Key Market Segments Covered In Global Corneal Ulcer Treatment Industry Research
By Drug class:
- Antibiotics
- Antifungals
- Antivirals
- Corticosteroids
- NSAID’s
By Form:
- Tablet
- Eye Drops/ Ointments
- Vials
By Route of Administration:
- Oral
- Topical
- Injectables
By Indication:
- Bacterial Keratitis
- Fungal Keratitis
- Viral Keratitis
Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/6953
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
